Jasper Therapeutics, Inc. · NASDAQ:JSPR
Integrated Core Strategies (US) LLC's stake in Jasper Therapeutics, Inc. fell to 1.70% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 10, 2026
Integrated Core Strategies (US) LLC's stake in Jasper Therapeutics, Inc. fell to 1.70%, 486,454 shares, as a passive investor on Jun 30, 2026. Filed Jul 10, 2026 (Schedule 13G/A).
- Stake
- 1.70%
- Shares
- 486,454
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 1.70% | 486,454 |
| Millennium Management LLC | 1.70% | 486,933 |
| Millennium Group Management LLC | 1.70% | 486,933 |
| Israel A. Englander | 1.70% | 486,933 |
Source
Related
- Jasper Therapeutics, Inc.
- Millennium Management LLC
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Millennium Management LLC · Feb 25, 2026
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026